2022
DOI: 10.17219/acem/152207
|View full text |Cite
|
Sign up to set email alerts
|

Schaftoside improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK/mTOR pathway

Abstract: improves cerebral ischemia-reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation through the AMPK/ mTOR pathway [published online as ahead of print on September 22, 2022].

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 66 publications
0
2
0
Order By: Relevance
“…Next, pretreatment with eugenol attenuated ischemia–reperfusion brain injury in rats by inducing autophagy via the AMPK/mTOR/P70S6K signaling pathway [ 111 ]. Another study indicated that schaftoside blocked apoptosis and neuroinflammation, reducing brain edema and improving neurologic deficits by enhancing autophagy after transient focal brain ischemia in rats [ 117 ].…”
Section: Autophagy Versus Postischemic Brain Injurymentioning
confidence: 99%
“…Next, pretreatment with eugenol attenuated ischemia–reperfusion brain injury in rats by inducing autophagy via the AMPK/mTOR/P70S6K signaling pathway [ 111 ]. Another study indicated that schaftoside blocked apoptosis and neuroinflammation, reducing brain edema and improving neurologic deficits by enhancing autophagy after transient focal brain ischemia in rats [ 117 ].…”
Section: Autophagy Versus Postischemic Brain Injurymentioning
confidence: 99%
“…Soyasaponin Bb exhibits significant anti‐thrombosis and hypolipidemic activities and could ameliorate obesity and reduce hepatic triacylglycerol accumulation by suppressing lipogenesis in high‐fat diet‐fed mice (Tsai et al, 2021). Schaftoside was the representative flavone and could improve cerebral ischemia–reperfusion injury by enhancing autophagy and reducing apoptosis and inflammation (Zhang et al, 2022), and exhibited anti‐epileptic effect by suppressing apoptosis and modulating inflammation (Dang et al, 2021). In addition, schaftoside could activate Farnesoid X Receptor and exhibited hepatoprotective activity by modulating oxidative stress and inflammation (Liu, Zhang, Song, et al, 2020; Liu, Zhang, Wu, et al, 2020).…”
Section: Introductionmentioning
confidence: 99%